Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Thickeners and Stabilizers
Fillers, Diluents & Binders
Direct Compression
Taste Masking
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Application : Chewable & Orodispersible Aids, Fillers, Diluents & Binders, Taste Masking
Excipient Details : Maltodextrin, derived from the partial hydrolysis of starch, used in tablet formulations as a binder and diluent. It is particularly useful in chewable tablet formulations.
SPI Pharma has been solving formulation challenges using superior functional materials.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Application : Direct Compression, Taste Masking
Excipient Details : CM90 is a directly compressible, granulated calcium carbonate with maltodextrin used for swallow tablets due to its high density and compressibility.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 490- 500, Tapped Density: 1.50
Ingredient(s) : Calcium Carbonate Excipient
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Maltodextrin is used in tablet formulations as a binder and diluent, and is particularly useful in tablet formulations.
Emulsifying Agents
Solubilizers
Granulation
Lubricants & Glidants
Coating Systems & Additives
Parenteral
Topical
Controlled & Modified Release
Chewable & Orodispersible Aids
Co-Processed Excipients
API Stability Enhancers
Film Formers & Plasticizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Clindamycin Palmitate Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clindamycin Palmitate Hydrochloride, including repackagers and relabelers. The FDA regulates Clindamycin Palmitate Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clindamycin Palmitate Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clindamycin Palmitate Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clindamycin Palmitate Hydrochloride supplier is an individual or a company that provides Clindamycin Palmitate Hydrochloride active pharmaceutical ingredient (API) or Clindamycin Palmitate Hydrochloride finished formulations upon request. The Clindamycin Palmitate Hydrochloride suppliers may include Clindamycin Palmitate Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clindamycin Palmitate Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Clindamycin Palmitate Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Clindamycin Palmitate Hydrochloride DMFs exist exist since differing nations have different regulations, such as Clindamycin Palmitate Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clindamycin Palmitate Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Clindamycin Palmitate Hydrochloride USDMF includes data on Clindamycin Palmitate Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clindamycin Palmitate Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with USDMF on PharmaCompass.
A Clindamycin Palmitate Hydrochloride written confirmation (Clindamycin Palmitate Hydrochloride WC) is an official document issued by a regulatory agency to a Clindamycin Palmitate Hydrochloride manufacturer, verifying that the manufacturing facility of a Clindamycin Palmitate Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clindamycin Palmitate Hydrochloride APIs or Clindamycin Palmitate Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Clindamycin Palmitate Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clindamycin Palmitate Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clindamycin Palmitate Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clindamycin Palmitate Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clindamycin Palmitate Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clindamycin Palmitate Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with NDC on PharmaCompass.
Clindamycin Palmitate Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clindamycin Palmitate Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clindamycin Palmitate Hydrochloride GMP manufacturer or Clindamycin Palmitate Hydrochloride GMP API supplier for your needs.
A Clindamycin Palmitate Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Clindamycin Palmitate Hydrochloride's compliance with Clindamycin Palmitate Hydrochloride specifications and serves as a tool for batch-level quality control.
Clindamycin Palmitate Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Clindamycin Palmitate Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clindamycin Palmitate Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Clindamycin Palmitate Hydrochloride EP), Clindamycin Palmitate Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clindamycin Palmitate Hydrochloride USP).
LOOKING FOR A SUPPLIER?
